chr11:34438934:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr11:34,460,481-34,493,607 |
hg38 | chr11:34,438,934-34,472,060 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.006 | squamous cell carcinoma | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Cardiovascular Diseases | NA | BeFree,GAD | Detail | |
0.120 | Neoplastic Cell Transformation | NA | CTD_human | Detail | |
0.200 | brain ischemia | NA | CTD_human,RGD | Detail | |
<0.001 | Malignant tumor of cervix | The role of CYBA (p22phox) and catalase genetic polymorphisms and their possible... | BeFree | 25307973 | Detail |
0.080 | cholestasis | NA | RGD | Detail | |
<0.001 | cholesterol ester storage disease | NA | BeFree | Detail | |
<0.001 | choriocarcinoma | NA | BeFree | Detail | |
0.001 | Congenital chromosomal disease | This study was conducted to determine the association between arsenic exposure a... | BeFree | 25395496 | Detail |
<0.001 | Cockayne syndrome | NA | BeFree | Detail | |
0.080 | colitis | NA | BeFree,RGD | Detail | |
<0.001 | ulcerative colitis | NA | BeFree | Detail | |
<0.001 | Colonic Neoplasms | NA | BeFree | Detail | |
0.003 | Coronary heart disease | NA | BeFree,GAD | Detail | |
<0.001 | cutis laxa | NA | BeFree | Detail | |
<0.001 | cystic fibrosis | NA | BeFree | Detail | |
<0.001 | Dental Plaque | NA | BeFree | Detail | |
<0.001 | dermatitis | NA | BeFree | Detail | |
0.001 | Diabetes | The aim of this study is to examine association of decreased blood catalase acti... | BeFree | 25772105 | Detail |
0.131 | diabetes mellitus | The aim of this study is to examine association of decreased blood catalase acti... | BeFree,CTD_human,GAD,LHGDN | 25772105 | Detail |
0.200 | Diabetes Mellitus, Experimental | NA | CTD_human,RGD | Detail | |
0.129 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,CTD_human,GAD | Detail | |
0.132 | Diabetes Mellitus, Non-Insulin-Dependent | Seven patients (type 2 diabetes (n=3), gestational diabetes (n=1), microcytic an... | BeFree,CTD_human,GAD | 25772105 | Detail |
0.003 | Diabetic Angiopathies | NA | BeFree,GAD | Detail | |
0.084 | Diabetic Nephropathy | NA | BeFree,GAD,RGD | Detail | |
0.123 | Diabetic Neuropathies | NA | BeFree,CTD_human,GAD | Detail | |
0.080 | diabetic retinopathy | NA | BeFree,RGD | Detail | |
0.009 | DNA Damage | NA | GAD | Detail | |
0.001 | Down syndrome | Using cultured fibroblasts with trisomy 21 (T21F), this study aimed to ascertain... | BeFree | 25852816 | Detail |
0.120 | Dyskinesia, Drug-Induced | NA | CTD_human | Detail | |
0.120 | Edema | NA | CTD_human | Detail | |
0.001 | Embryopathies | Embryonic catalase protects against ethanol embryopathies in acatalasemic mice a... | BeFree | 26074427 | Detail |
<0.001 | Empyema | NA | BeFree | Detail | |
<0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
0.003 | endometriosis | NA | LHGDN | Detail | |
<0.001 | Fanconi anemia | NA | BeFree | Detail | |
0.200 | Fatty Liver | NA | BeFree,CTD_human,RGD | Detail | |
<0.001 | fragile X syndrome | NA | BeFree | Detail | |
<0.001 | Friedreich ataxia | NA | BeFree | Detail | |
<0.001 | gastritis | NA | BeFree | Detail | |
<0.001 | gastroenteritis | NA | BeFree | Detail | |
0.120 | Glioma | NA | CTD_human | Detail | |
<0.001 | gonorrhea | NA | BeFree | Detail | |
0.002 | chronic granulomatous disease | NA | BeFree | Detail | |
0.080 | Sensorineural Hearing Loss (disorder) | NA | RGD | Detail | |
<0.001 | cardiac arrest | NA | BeFree | Detail | |
0.120 | Heart failure | NA | BeFree,CTD_human | Detail | |
<0.001 | congestive heart failure | NA | BeFree | Detail | |
0.120 | hepatitis | NA | CTD_human | Detail | |
<0.001 | hepatitis B | NA | BeFree | Detail | |
0.120 | Hepatitis, Chronic | NA | CTD_human | Detail | |
<0.001 | Hepatolenticular Degeneration | Variability within the CAT gene may be an important modifier of the clinical cou... | BeFree | 24517502 | Detail |
<0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
0.007 | HIV Infections | Specific amplification of gene encoding N-terminal region of catalase-peroxidase... | BeFree | 25070007 | Detail |
0.080 | Huntington disease | NA | RGD | Detail | |
0.080 | Hyperalgesia | NA | RGD | Detail | |
0.120 | Hyperemia | NA | CTD_human | Detail | |
<0.001 | hyperglycemia | NA | BeFree | Detail | |
0.219 | Hypertensive disease | Changes in the CAT levels were reported in many different diseases and polymorph... | BeFree,CTD_human,GAD,LHGDN,RGD | 25152049 | Detail |
0.219 | Hypertensive disease | Environmental lead exposure, catalase gene, and markers of antioxidant and oxida... | BeFree,CTD_human,GAD,LHGDN,RGD | 25793211 | Detail |
0.200 | hyperthyroidism | NA | CTD_human,RGD | Detail | |
0.120 | Hypotension | NA | CTD_human | Detail | |
<0.001 | male infertility | Human catalase gene polymorphism (CAT C-262T) and risk of male infertility. | BeFree | 24456074 | Detail |
0.005 | Inflammation | NA | GAD,LHGDN | Detail | |
<0.001 | influenza | Ability of recombinant human catalase to suppress inflammation of the murine lun... | BeFree | 24385240 | Detail |
0.002 | Insulin resistance | NA | GAD | Detail | |
<0.001 | insulinoma | NA | BeFree | Detail | |
0.002 | ischemia | NA | BeFree | Detail | |
<0.001 | keratoconus | NA | BeFree | Detail | |
0.120 | keratosis | NA | CTD_human | Detail | |
<0.001 | kernicterus | NA | BeFree | Detail | |
0.120 | Kidney Calculi | NA | CTD_human | Detail | |
0.003 | Kidney Diseases | NA | BeFree,GAD | Detail | |
<0.001 | Kidney Failure, Acute | NA | BeFree | Detail | |
0.203 | Kidney Failure, Chronic | NA | BeFree,CTD_human,GAD,RGD | Detail | |
0.002 | leukemia | NA | GAD | Detail | |
<0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
<0.001 | Leukoencephalopathy, Progressive Multifocal | NA | BeFree | Detail | |
<0.001 | listeriosis | NA | BeFree | Detail | |
0.123 | Liver Cirrhosis, Alcoholic | NA | BeFree,CTD_human,GAD | Detail | |
0.008 | Liver neoplasms | NA | BeFree,GAD | Detail | |
0.083 | Lung diseases | NA | BeFree,LHGDN,RGD | Detail | |
0.008 | Chronic Obstructive Airway Disease | NA | BeFree,GAD,LHGDN | Detail | |
0.012 | Lupus Erythematosus, Systemic | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | lymphoma | NA | BeFree | Detail | |
0.003 | Lymphoma, Non-Hodgkin | For the TYMS gene, haplotype CAT at TYMS (OR 0.67, 95% CI 0.49-0.90, P = 0.007) ... | BeFree,GAD | 25384508 | Detail |
<0.001 | malaria | Host genetic variations in glutathione-S-transferases, superoxide dismutases and... | BeFree | 25573779 | Detail |
<0.001 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
0.120 | Marfan syndrome | NA | CTD_human | Detail | |
0.003 | melanoma | NA | BeFree,GAD | Detail | |
<0.001 | Mental Retardation | NA | BeFree | Detail | |
0.120 | Mesothelioma | NA | CTD_human | Detail | |
<0.001 | Metabolic Diseases | NA | BeFree | Detail | |
<0.001 | microcephaly | NA | BeFree | Detail | |
<0.001 | Monosomy | NA | BeFree | Detail | |
<0.001 | Mouth Diseases | However, prolonged incubation with both stimuli induced a reduction of catalase ... | BeFree | 25374447 | Detail |
0.002 | Mouth Neoplasms | NA | GAD | Detail | |
0.003 | multiple sclerosis | NA | LHGDN | Detail | |
<0.001 | Mycoses | NA | BeFree | Detail | |
0.200 | myocardial infarction | NA | CTD_human,RGD | Detail | |
0.200 | Myocardial Reperfusion Injury | NA | CTD_human,RGD | Detail | |
0.120 | Necrosis | NA | CTD_human | Detail | |
0.120 | Neoplasm Invasiveness | NA | CTD_human | Detail | |
0.121 | Neoplasm Metastasis | NA | BeFree,CTD_human | Detail | |
0.003 | nephroblastoma | NA | BeFree | Detail | |
0.002 | neuroblastoma | NA | BeFree | Detail | |
<0.001 | obesity | NA | BeFree | Detail | |
0.002 | Occupational Diseases | NA | GAD | Detail | |
<0.001 | optic neuritis | NA | BeFree | Detail | |
<0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
0.002 | Bone necrosis | NA | GAD | Detail | |
<0.001 | osteoporosis | NA | BeFree | Detail | |
0.120 | Osteoporosis, Postmenopausal | NA | CTD_human | Detail | |
<0.001 | osteosarcoma | NA | BeFree | Detail | |
0.080 | otitis media | NA | RGD | Detail | |
<0.001 | ovarian carcinoma | NA | BeFree | Detail | |
0.002 | Pancreatic Neoplasm | NA | GAD | Detail | |
0.002 | pancreatitis | NA | GAD | Detail | |
<0.001 | Parkinson disease | We demonstrated earlier systemically administered autologous macrophages can del... | BeFree | 25229627 | Detail |
<0.001 | pericardial effusion | NA | BeFree | Detail | |
<0.001 | pericarditis | NA | BeFree | Detail | |
0.080 | Phenylketonurias | NA | RGD | Detail | |
<0.001 | pheochromocytoma | NA | BeFree | Detail | |
<0.001 | Pituitary Diseases | NA | BeFree | Detail | |
<0.001 | Pituitary Neoplasms | NA | BeFree | Detail | |
<0.001 | plasmacytoma | NA | BeFree | Detail | |
0.120 | Precancerous Conditions | NA | BeFree,CTD_human | Detail | |
0.120 | Protein Deficiency | NA | CTD_human | Detail | |
0.002 | pseudoxanthoma elasticum | NA | GAD | Detail | |
0.123 | psoriasis | NA | BeFree,CTD_human,LHGDN | Detail | |
0.120 | pulmonary edema | NA | CTD_human | Detail | |
0.120 | pulmonary embolism | NA | CTD_human | Detail | |
<0.001 | pulmonary emphysema | NA | BeFree | Detail | |
0.003 | purpura | NA | LHGDN | Detail | |
<0.001 | Refsum disease | NA | BeFree | Detail | |
0.200 | Reperfusion Injury | NA | CTD_human,RGD | Detail | |
0.002 | Respiratory Tract Diseases | NA | GAD | Detail | |
0.080 | Retinal Diseases | NA | RGD | Detail | |
<0.001 | sarcoidosis | NA | BeFree | Detail | |
0.120 | Seizures | NA | CTD_human | Detail | |
<0.001 | Sickle Cell Trait | NA | BeFree | Detail | |
0.002 | Skin Neoplasms | NA | GAD | Detail | |
0.120 | status epilepticus | NA | CTD_human | Detail | |
0.200 | gastric ulcer | NA | CTD_human,RGD | Detail | |
0.080 | stomatitis | NA | RGD | Detail | |
<0.001 | Cerebrovascular accident | NA | BeFree | Detail | |
0.002 | Sunburn | NA | GAD | Detail | |
<0.001 | Superinfection | NA | BeFree | Detail | |
0.003 | tuberculosis | NA | BeFree | Detail | |
0.120 | Turner syndrome | NA | CTD_human | Detail | |
<0.001 | Unipolar Depression | Likewise, the gene expression of oxidative defence enzymes superoxide dismutases... | BeFree | 24967945 | Detail |
0.080 | ureteral obstruction | NA | RGD | Detail | |
0.003 | urticaria | NA | LHGDN | Detail | |
<0.001 | Vascular Diseases | NA | BeFree | Detail | |
0.018 | vitiligo | Changes in the CAT levels were reported in many different diseases and polymorph... | BeFree,GAD | 25152049 | Detail |
<0.001 | Werner syndrome | NA | BeFree | Detail | |
0.003 | xeroderma pigmentosum | NA | BeFree | Detail | |
0.001 | Zellweger syndrome | NA | BeFree | Detail | |
<0.001 | Hallopeau-Siemens Disease | NA | BeFree | Detail | |
0.120 | diffuse large B-cell lymphoma | NA | CTD_human | Detail | |
<0.001 | eosinophilia-myalgia syndrome | NA | BeFree | Detail | |
<0.001 | gestational diabetes | In patients with decreased blood catalase, the incidence of acatalasemia mutatio... | BeFree | 25772105 | Detail |
<0.001 | Iron-refractory iron deficiency anemia | In patients with decreased blood catalase, the incidence of acatalasemia mutatio... | BeFree | 25772105 | Detail |
<0.001 | essential hypertension | NA | BeFree | Detail | |
0.002 | Alcohol abuse | NA | GAD | Detail | |
0.080 | cataract | NA | RGD | Detail | |
<0.001 | Ataxia, Spinocerebellar | NA | BeFree | Detail | |
0.003 | Pancreatitis, Chronic | NA | BeFree,GAD | Detail | |
0.080 | Left Ventricular Hypertrophy | NA | RGD | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
0.080 | sciatic neuropathy | NA | RGD | Detail | |
0.120 | Premature Birth | NA | CTD_human | Detail | |
<0.001 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
0.003 | Malnutrition | NA | BeFree,GAD | Detail | |
<0.001 | variegate porphyria | NA | BeFree | Detail | |
<0.001 | Hypopigmentation disorder | NA | BeFree | Detail | |
<0.001 | Aortic Aneurysm, Thoracic | NA | BeFree | Detail | |
<0.001 | fatal familial insomnia | NA | BeFree | Detail | |
<0.001 | myocardial stunning | NA | BeFree | Detail | |
0.001 | hepatoblastoma | NA | BeFree | Detail | |
<0.001 | embryonal carcinoma | NA | BeFree | Detail | |
<0.001 | gonadoblastoma | NA | BeFree | Detail | |
<0.001 | teratocarcinoma | NA | BeFree | Detail | |
<0.001 | Follicular thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
<0.001 | Congenital defects | NA | BeFree | Detail | |
<0.001 | alpha 1-antitrypsin deficiency | NA | BeFree | Detail | |
<0.001 | Extrapyramidal sign | NA | BeFree | Detail | |
0.080 | Neurotoxicity Syndromes | NA | RGD | Detail | |
<0.001 | Cerebral atrophy | NA | BeFree | Detail | |
<0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
0.002 | Substance-Related Disorders | NA | GAD | Detail | |
<0.001 | Anaplastic thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Medullary carcinoma of thyroid | NA | BeFree | Detail | |
<0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
0.002 | Dyslipidemias | NA | GAD | Detail | |
0.002 | Malignant neoplasm of lung | NA | BeFree | Detail | |
0.002 | age related macular degeneration | NA | GAD | Detail | |
0.120 | Acute Lung Injury | NA | CTD_human | Detail | |
0.120 | Disease Progression | NA | CTD_human | Detail | |
0.080 | Sepsis | NA | RGD | Detail | |
<0.001 | Chronic Periodontitis | NA | BeFree | Detail | |
0.362 | acatalasia | NA | BeFree,CLINVAR,CTD_human,ORPHANET | Detail | |
<0.001 | Pipecolic acidemia | NA | BeFree | Detail | |
<0.001 | Spastic syndrome | NA | BeFree | Detail | |
0.002 | Impaired glucose tolerance | NA | GAD | Detail | |
<0.001 | Aspergilloma | NA | BeFree | Detail | |
0.002 | Cancer of Head and Neck | NA | GAD | Detail | |
<0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
<0.001 | Adrenoleukodystrophy, Neonatal | NA | BeFree | Detail | |
0.001 | Infantile Refsum Disease (disorder) | NA | BeFree | Detail | |
0.001 | cervix carcinoma | The role of CYBA (p22phox) and catalase genetic polymorphisms and their possible... | BeFree | 25307973 | Detail |
<0.001 | Acute ulcer | NA | BeFree | Detail | |
<0.001 | Impaired cognition | NA | BeFree | Detail | |
0.002 | Complications of Diabetes Mellitus | NA | GAD | Detail | |
<0.001 | MRSA - Methicillin resistant Staphylococcus aureus infection | The mortality rate of the present study was 11.8%, suggesting that the clinical ... | BeFree | 25361922 | Detail |
<0.001 | malignant mesothelioma | NA | BeFree | Detail | |
0.120 | Phobic anxiety disorder | NA | CTD_human | Detail | |
<0.001 | prediabetes syndrome | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
<0.001 | Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of prostate | This study of advanced prostate cancer risk showed a marginal association with a... | BeFree | 25315963 | Detail |
0.002 | Malignant neoplasm of prostate | Catalase C-262T polymorphism and risk of prostate cancer: evidence from meta-ana... | BeFree | 25576221 | Detail |
0.120 | Chromosome Breakage | NA | CTD_human | Detail | |
<0.001 | Chronic Kidney Insufficiency | NA | BeFree | Detail | |
<0.001 | Senile sclerosis of aortic cusp | NA | BeFree | Detail | |
<0.001 | endometrial carcinoma | NA | BeFree | Detail | |
<0.001 | Overweight | NA | BeFree | Detail | |
<0.001 | Clumsiness - motor delay | NA | BeFree | Detail | |
<0.001 | Metabolic syndrome X | NA | BeFree | Detail | |
<0.001 | Neurodegenerative Disorders | NA | BeFree | Detail | |
<0.001 | Hepatitis B, Chronic | Association between catalase gene polymorphisms and risk of chronic hepatitis B,... | BeFree | 25837767 | Detail |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Alcoholic Intoxication, Chronic | Four polymorphisms were evaluated, including the serotonin transporter HTTLPR pr... | BeFree | 15654286 | Detail |
0.009 | liver carcinoma | No significant associations were observed between three other polymorphisms (MnS... | BeFree | 25894370 | Detail |
0.123 | Liver Cirrhosis, Alcoholic | Our aim was to determine whether Ala16Val-superoxide dismutase 2 (SOD2), G-463A-... | BeFree | 19731237 | Detail |
0.009 | liver carcinoma | Our aim was to determine whether Ala16Val-superoxide dismutase 2 (SOD2), G-463A-... | BeFree | 19731237 | Detail |
<0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
0.002 | prostate carcinoma | This study of advanced prostate cancer risk showed a marginal association with a... | BeFree | 25315963 | Detail |
0.002 | prostate carcinoma | Catalase C-262T polymorphism and risk of prostate cancer: evidence from meta-ana... | BeFree | 25576221 | Detail |
<0.001 | Lung Diseases, Obstructive | NA | BeFree | Detail | |
<0.001 | toxic shock syndrome | Clonal spread of catalase-negative ST5/SCCmec II Staphylococcus aureus carrying ... | BeFree | 25361922 | Detail |
<0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
0.007 | breast carcinoma | NA | BeFree | Detail | |
0.002 | Carcinoma of lung | NA | BeFree | Detail | |
<0.001 | colon carcinoma | NA | BeFree | Detail | |
<0.001 | stomach carcinoma | NA | BeFree | Detail | |
0.002 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | asthma adult onset | NA | BeFree | Detail | |
<0.001 | mitral valve endocarditis | NA | BeFree | Detail | |
<0.001 | Hypocatalasemia | NA | BeFree | Detail | |
0.001 | spinocerebellar ataxia type 1 | NA | BeFree | Detail | |
<0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori infection | NA | BeFree | Detail | |
<0.001 | Oestrogen deficiency | The results show that EBNs significantly decreased estrogen deficiency-associate... | BeFree | 25920003 | Detail |
<0.001 | Endothelial dysfunction | NA | BeFree | Detail | |
0.120 | Drug-Induced Liver Injury | NA | CTD_human | Detail | |
0.003 | Hyperkeratosis | NA | BeFree,GAD | Detail | |
<0.001 | latent infection | NA | BeFree | Detail | |
<0.001 | Beta thalassemia trait | NA | BeFree | Detail | |
0.121 | Cardiomyopathies | NA | BeFree,CTD_human | Detail | |
0.120 | Arthritis, Experimental | NA | CTD_human | Detail | |
<0.001 | Macroangiopathy | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the head and neck | We investigated the activity of the following antioxidant enzymes: superoxide di... | BeFree | 25489965 | Detail |
0.080 | Renoprival hypertension | NA | RGD | Detail | |
<0.001 | Ductal Carcinoma | NA | BeFree | Detail | |
<0.001 | diffuse scleroderma | NA | BeFree | Detail | |
<0.001 | Female genital tract infection | NA | BeFree | Detail | |
0.120 | major depressive disorder | Likewise, the gene expression of oxidative defence enzymes superoxide dismutases... | BeFree,CTD_human | 24967945 | Detail |
<0.001 | Avellino corneal dystrophy | NA | BeFree | Detail | |
<0.001 | Generalized vitiligo | NA | BeFree | Detail | |
<0.001 | Infiltrating Cervical Carcinoma | The CYBA C-242T and CAT C-262T genetic polymorphisms and their epistatic interac... | BeFree | 25307973 | Detail |
<0.001 | Pleural Mesothelioma | NA | BeFree | Detail | |
<0.001 | Aortic valve sclerosis | NA | BeFree | Detail | |
0.120 | Ureteral Calculi | NA | CTD_human | Detail | |
0.127 | Mammary Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
0.003 | colorectal cancer | NA | BeFree,GAD | Detail | |
<0.001 | Ductal Breast Carcinoma | NA | BeFree | Detail | |
<0.001 | Arterial leg ulcer | NA | BeFree | Detail | |
<0.001 | Chronic Kidney Diseases | NA | BeFree | Detail | |
0.002 | Delayed Graft Function | NA | GAD | Detail | |
0.080 | Prehypertension | NA | RGD | Detail | |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | Recurrent infections (sinusitis and bacterial pneumonia and meningitis) | NA | BeFree | Detail | |
0.006 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | Changes in the CAT levels were reported in many different diseases and polymorph... | BeFree | 25152049 | Detail |
<0.001 | AMYOTROPHIC LATERAL SCLEROSIS 1 | NA | BeFree | Detail | |
<0.001 | Amyotrophic Lateral Sclerosis, Sporadic | NA | BeFree | Detail | |
<0.001 | Trichothiodystrophy Syndromes | NA | BeFree | Detail | |
<0.001 | coronary artery disease | NA | BeFree | Detail | |
<0.001 | Reproductive tract infection | NA | BeFree | Detail | |
<0.001 | Pediatric Obesity | NA | BeFree | Detail | |
0.002 | Radiotoxicity | NA | GAD | Detail | |
<0.001 | Chronic ulcerative colitis | NA | BeFree | Detail | |
0.001 | Catalase deficiency | NA | BeFree | Detail | |
0.121 | Acatalasemia Japanese type | NA | BeFree,CLINVAR | Detail | |
0.002 | Solar Erythema | NA | GAD | Detail | |
<0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
<0.001 | alpha-1-Antitrypsin Deficiency, Autosomal Recessive | NA | BeFree | Detail | |
<0.001 | Congenital Abnormality | NA | BeFree | Detail | |
<0.001 | Abscess | NA | BeFree | Detail | |
<0.001 | actinomycosis | NA | BeFree | Detail | |
<0.001 | acute pancreatitis | NA | BeFree | Detail | |
0.003 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | adenoma | NA | BeFree | Detail | |
0.005 | Albuminuria | NA | GAD | Detail | |
<0.001 | Alcoholic Intoxication, Chronic | Our findings suggest that the CAT c.-262C>T genetic polymorphism influences the ... | BeFree | 25514903 | Detail |
0.003 | Alzheimer's disease | NA | BeFree,GAD | Detail | |
<0.001 | amyotrophic lateral sclerosis | Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes... | BeFree | 25054289 | Detail |
<0.001 | Refractory anaemia with excess blasts | NA | BeFree | Detail | |
0.003 | aniridia | NA | BeFree | Detail | |
<0.001 | Anxiety Disorders | Our findings suggest that the CAT c.-262C>T genetic polymorphism influences the ... | BeFree | 25514903 | Detail |
0.120 | Aortic Diseases | NA | CTD_human | Detail | |
0.001 | arteriosclerosis | NA | BeFree | Detail | |
0.126 | rheumatoid arthritis | The diminished activities of pancreatic superoxide dismutase (SOD), catalase (CA... | BeFree,CTD_human,GAD,LHGDN | 25735949 | Detail |
0.003 | asbestosis | NA | BeFree,GAD | Detail | |
<0.001 | aspergillosis | NA | BeFree | Detail | |
<0.001 | Aspergillosis, Allergic Bronchopulmonary | NA | BeFree | Detail | |
0.120 | asphyxia neonatorum | NA | CTD_human | Detail | |
0.133 | asthma | The aim of this study was to examine the association of manganese superoxide dis... | BeFree,CTD_human,GAD,LHGDN | 25931357 | Detail |
<0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
0.003 | atherosclerosis | NA | BeFree,GAD | Detail | |
0.120 | autistic disorder | NA | CTD_human | Detail | |
<0.001 | Bacteremia | NA | BeFree | Detail | |
0.080 | Pneumonia, Bacterial | NA | RGD | Detail | |
<0.001 | Barrett esophagus | BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's E... | BeFree | 25869390 | Detail |
0.120 | Behcet Syndrome | NA | CTD_human | Detail | |
0.001 | beta thalassemia | The aim of this study is to examine association of decreased blood catalase acti... | BeFree | 25772105 | Detail |
<0.001 | bipolar disorder | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of urinary bladder | NA | GAD | Detail | |
0.005 | Brain Neoplasms | NA | GAD,LHGDN | Detail | |
0.025 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
0.080 | bronchopulmonary dysplasia | NA | RGD | Detail | |
<0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
0.002 | basal cell carcinoma | NA | GAD | Detail | |
0.121 | Non-small cell lung carcinoma | NA | BeFree,CTD_human | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of CYBA (p22phox) and catalase genetic polymorphisms and their possible epistatic interacti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study was conducted to determine the association between arsenic exposure and polymorphisms of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study is to examine association of decreased blood catalase activity and catalase ex... | DisGeNET | Detail |
The aim of this study is to examine association of decreased blood catalase activity and catalase ex... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Seven patients (type 2 diabetes (n=3), gestational diabetes (n=1), microcytic anemia (n=2)) had four... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Using cultured fibroblasts with trisomy 21 (T21F), this study aimed to ascertain whether an imbalanc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Embryonic catalase protects against ethanol embryopathies in acatalasemic mice and transgenic human ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Variability within the CAT gene may be an important modifier of the clinical course of WD. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Specific amplification of gene encoding N-terminal region of catalase-peroxidase protein (KatG-N) fo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Changes in the CAT levels were reported in many different diseases and polymorphisms in the CAT gene... | DisGeNET | Detail |
Environmental lead exposure, catalase gene, and markers of antioxidant and oxidative stress relation... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Human catalase gene polymorphism (CAT C-262T) and risk of male infertility. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Ability of recombinant human catalase to suppress inflammation of the murine lung induced by influen... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
For the TYMS gene, haplotype CAT at TYMS (OR 0.67, 95% CI 0.49-0.90, P = 0.007) was associated with ... | DisGeNET | Detail |
Host genetic variations in glutathione-S-transferases, superoxide dismutases and catalase genes infl... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, prolonged incubation with both stimuli induced a reduction of catalase indicating a collaps... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We demonstrated earlier systemically administered autologous macrophages can deliver nanoformulated ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Likewise, the gene expression of oxidative defence enzymes superoxide dismutases (SOD1 and SOD2), ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Changes in the CAT levels were reported in many different diseases and polymorphisms in the CAT gene... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In patients with decreased blood catalase, the incidence of acatalasemia mutations was significantly... | DisGeNET | Detail |
In patients with decreased blood catalase, the incidence of acatalasemia mutations was significantly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The role of CYBA (p22phox) and catalase genetic polymorphisms and their possible epistatic interacti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The mortality rate of the present study was 11.8%, suggesting that the clinical relevance of catalas... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study of advanced prostate cancer risk showed a marginal association with a CAT polymorphism an... | DisGeNET | Detail |
Catalase C-262T polymorphism and risk of prostate cancer: evidence from meta-analysis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-r... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Four polymorphisms were evaluated, including the serotonin transporter HTTLPR promoter ins/del, GABA... | DisGeNET | Detail |
No significant associations were observed between three other polymorphisms (MnSOD Ala16Val, CAT-262... | DisGeNET | Detail |
Our aim was to determine whether Ala16Val-superoxide dismutase 2 (SOD2), G-463A-MPO, or T-262C-CAT d... | DisGeNET | Detail |
Our aim was to determine whether Ala16Val-superoxide dismutase 2 (SOD2), G-463A-MPO, or T-262C-CAT d... | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study of advanced prostate cancer risk showed a marginal association with a CAT polymorphism an... | DisGeNET | Detail |
Catalase C-262T polymorphism and risk of prostate cancer: evidence from meta-analysis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Clonal spread of catalase-negative ST5/SCCmec II Staphylococcus aureus carrying the staphylococcal e... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The results show that EBNs significantly decreased estrogen deficiency-associated serum elevation of... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We investigated the activity of the following antioxidant enzymes: superoxide dismutase (SOD), catal... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Likewise, the gene expression of oxidative defence enzymes superoxide dismutases (SOD1 and SOD2), ca... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The CYBA C-242T and CAT C-262T genetic polymorphisms and their epistatic interactions can be associa... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Changes in the CAT levels were reported in many different diseases and polymorphisms in the CAT gene... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings suggest that the CAT c.-262C>T genetic polymorphism influences the susceptibility to al... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes without extending t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings suggest that the CAT c.-262C>T genetic polymorphism influences the susceptibility to al... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The diminished activities of pancreatic superoxide dismutase (SOD), catalase (CAT), glutathione pero... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to examine the association of manganese superoxide dismutase (MnSOD) Ala16... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dys... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study is to examine association of decreased blood catalase activity and catalase ex... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386539811 dbSNP
- Genome
- hg38
- Position
- chr11:34,438,934-34,472,060
- Variant Type
- snv
Genome browser